Two lawmakers behind the Cures Act have asked the Office of Management and Budget to clarify whether the federal hiring freeze applies to the FDA, raising concerns that the freeze…
A complaint from the Federal Trade Commission alleges Shire ViroPharma unlawfully stifled competition for its branded drugs. Source: Drug Industry Daily
Two congressmen introduced right-to-try legislation in the House this week, which could find broad support from Congress and the White House. Source: Drug Industry Daily
More than 160 biotech executives, investors and researchers have signed on to a letter opposing President Trump’s executive order restricting immigration from seven Middle Eastern and African countries. Source: Drug…
Teva Pharmaceuticals has been named in a patent infringement lawsuit as it attempts to develop a generic version of Belbuca, a long-acting opioid painkiller sponsored by BioDelivery Sciences International and…
In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza. Source: Drug Industry Daily
Aspen Pharma and Deco Pharma, the company’s distributor, face disciplinary proceedings from Spain’s antitrust authority for allegedly limiting the distribution and hiking the prices of drugs. Source: Drug Industry Daily
A lawsuit filed by the state of California alleges several drug manufacturers made a “pay-for-delay” deal to keep generic competition off the market. Source: Drug Industry Daily
Former FDA deputy commissioner Scott Gottlieb emerged as the favorite to serve as the next leader of the FDA in a survey of 53 pharmaceutical companies. Source: Drug Industry Daily
The FTC is asking a Georgia federal court to remove Par Pharmaceuticals and Paddock Laboratories from an antitrust case that alleges the companies delayed the market entry of their AndroGel…